Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 214985
Company: IDORSIA
Company: IDORSIA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | EQ 25MG BASE | TABLET;ORAL | Prescription | None | Yes | No |
| QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | EQ 50MG BASE | TABLET;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes |
|---|---|---|---|---|---|---|
| 01/07/2022 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Federal Register Notice (PDF)
Label (PDF) Letter (PDF) Review |
FR Notice on DEA Scheduling Date of Approval - April 7, 2022 |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note |
|---|---|---|---|---|
| 09/30/2024 | SUPPL-12 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
|
| 09/30/2024 | SUPPL-11 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
|
| 09/30/2024 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
|
| 10/30/2023 | SUPPL-8 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
|
| 10/30/2023 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
|
| 06/28/2023 | SUPPL-5 | Labeling-Container/Carton Labels |
Label is not available on this site. |
|
| 03/24/2023 | SUPPL-4 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
|
|
| 11/08/2022 | SUPPL-2 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note |
|---|---|---|---|---|
| 09/30/2024 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | |
| 09/30/2024 | SUPPL-11 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | |
| 09/30/2024 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | |
| 10/30/2023 | SUPPL-8 | Labeling-Package Insert | Label (PDF) | |
| 10/30/2023 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | |
| 03/24/2023 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | |
| 03/24/2023 | SUPPL-4 | Labeling-Medication Guide | Label (PDF) | |
| 11/08/2022 | SUPPL-2 | Labeling-Medication Guide | Label (PDF) | |
| 11/08/2022 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | |
| 01/07/2022 | ORIG-1 | Approval | Label (PDF) |